Gamal Baroud
Corporate Officer/Principal bei University of Sherbrooke
Profil
Gamal Baroud is the founder of Skeltex Technologies, Inc. which was founded in 2007.
He held the titles of President, Director & Chief Technology Officer.
Currently, he is a Professor at the University of Sherbrooke.
He previously worked as the Chairman of Canada Research Chairs Program.
Dr. Baroud has a graduate and doctorate degree from Chemnitz University of Technology and an undergraduate degree from FH Aachen University of Applied Sciences.
Aktive Positionen von Gamal Baroud
| Unternehmen | Position | Beginn |
|---|---|---|
| University of Sherbrooke | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Gamal Baroud
| Unternehmen | Position | Ende |
|---|---|---|
| Canada Research Chairs Program | Vorsitzender | - |
Skeltex Technologies, Inc.
 Skeltex Technologies, Inc. Medical SpecialtiesHealth Technology Skeltex Technologies, Inc. develops and manufactures devices in the field of interventional radiology and orthopedic surgery. It provided its products to improve health outcomes for patients with back pain due to spine fractures. The firm's primary technology was a device used for vertebroplasty, a minimally invasive procedures designed to treat pain from vertebral compression fractures (VCF). The company was founded by Gamal Baroud in 2007 and was headquartered in Boucherville, Canada. | Gründer | - |
Ausbildung von Gamal Baroud
| FH Aachen University of Applied Sciences | Undergraduate Degree |
| Chemnitz University of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Skeltex Technologies, Inc.
Skeltex Technologies, Inc. Medical SpecialtiesHealth Technology Skeltex Technologies, Inc. develops and manufactures devices in the field of interventional radiology and orthopedic surgery. It provided its products to improve health outcomes for patients with back pain due to spine fractures. The firm's primary technology was a device used for vertebroplasty, a minimally invasive procedures designed to treat pain from vertebral compression fractures (VCF). The company was founded by Gamal Baroud in 2007 and was headquartered in Boucherville, Canada. | Health Technology |
| Canada Research Chairs Program | Government |
